Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victims

Molecular Psychiatry volume 9, pages 184–190 (2004)Cite this article

Abstract

Endogenous and exogenous cannabinoids (CBs) acting through the CB1 receptors have been implicated in the regulation of several behavioral and neuroendocrine functions. Modulation of endocannabinoidergic system by ethanol in mouse brain, and the association of suicide and mood disorders with alcoholism suggest possible involvement of the cannabinoidergic system in the pathophysiology of depression and suicide. Therefore, the present study was undertaken to examine the levels of CB1 receptors and mediated signaling in the dorsolateral prefrontal cortex (DLPFC) of subjects with major depression who had died by suicides (depressed suicides, DS). [3H]CP-55,940 and CB1 receptor-stimulated [35S]GTPγS binding sites were analyzed in membranes obtained from DLPFC of DS (10) and matched normal controls (10). Upregulation (24%, P<0.0001) of CB1 receptor density (Bmax) was observed in DS (644.6±48.8 fmol/mg protein) compared with matched controls (493.3±52.7 fmol/mg protein). However, there was no significant alteration in the affinity of receptor (DS; 1.14±0.08 vs control; 1.12±0.10 nM). Higher density of CB1 receptors in DS (38%, P<0.001) was also demonstrated by Western blot analysis. The CB1 receptor-stimulated [35S]GTPγS binding was significantly greater (45%, P<0.001) in the DLPFC of DS compared with matched controls. The observed upregulation of CB1 receptors with concomitant increase in the CB1 receptor-mediated [35S]GTPγS binding suggests a role for enhanced cannabinoidergic signaling in the prefrontal cortex of DS. The cannabinoidergic system may be a novel therapeutic target in the treatment of depression and/or suicidal behavior.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

References

  1. Dewey WL . Cannabinoid pharmacology. Pharmacol Rev 1986; 38: 151–178.

    CAS  PubMed  Google Scholar 

  2. Hollister LE . Health aspects of cannabis. Pharmacol Rev 1986; 38: 1–20.

    CAS  PubMed  Google Scholar 

  3. Abood ME, Martin BR . Neurobiology of marijuana abuse. Trends Pharmacol Sci 1992; 13: 201–206.

    Article  CAS  PubMed  Google Scholar 

  4. Iverson LL . The Science of Marjuana. Oxford University Press: NY, 2000, p 36.

  5. Piomelli D, Giuffrida A, Calignano A, Rodriguez de Fonseca F . The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci 2000; 21: 218–224.

    Article  CAS  PubMed  Google Scholar 

  6. Pertwee R . Cannabinoids and multiple sclerosis. Pharmacol Ther 2002; 95: 165.

    Article  CAS  PubMed  Google Scholar 

  7. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI . Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561–564.

    Article  CAS  PubMed  Google Scholar 

  8. Munro S, Thomas KL, Abu-Shaar M . Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365: 61–65.

    Article  CAS  PubMed  Google Scholar 

  9. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258: 1946–1949.

    Article  CAS  PubMed  Google Scholar 

  10. Sugiura T, Konda S, Sukagawa A, Nakane S, Shinoda A, Itoh K et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995; 215: 89–97.

    Article  CAS  PubMed  Google Scholar 

  11. Pertwee RG, Stevenson LA, Elrick DB, Mechoulam R, Corbett AD . Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br J Pharmacol 1992; 105: 980–984.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kaminski NE, Abood ME, Kessler FK, Martin BR, Schatz AR . Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol Pharmacol 1992; 42: 736–742.

    CAS  PubMed  Google Scholar 

  13. Howlett AC, Qualy JM, Khachatrian LL . Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 1986; 29: 307–313.

    CAS  PubMed  Google Scholar 

  14. Herkenham M, Lynn AB, Johnson MR, Melvin LS, deCost BR, Rice KC . Characterization and localization of cannabinoid receptors in rat brain; a quantitative in vitro autoradiographic study. J Neurosci 1991; 16: 8057–8066.

    Google Scholar 

  15. Glass M, Dragunow M, Faull RL . Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997; 77: 299–318.

    Article  CAS  PubMed  Google Scholar 

  16. Westlake TM, Howlett AC, Bonner TI, Matsuda LA, Herkenham M . Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience 1994; 63: 637–652.

    Article  CAS  PubMed  Google Scholar 

  17. Glass M, Faull RL, Dragunow M . A significant loss of cannabinoid receptors in the substantia nigra in Huntington's disease. Neuroscience 1993; 56: 523–527.

    Article  CAS  PubMed  Google Scholar 

  18. Arango V, Underwood MD, Mann JJ . Serotonin brain circuits involved in major depression and suicide. Prog Brain Res 2002; 136: 443–453.

    Article  CAS  PubMed  Google Scholar 

  19. Gonzalez-Maeso J, Rodriguez-Puertas R, Meana JJ, Garcia-Sevilla JA, Guimon J . Neurotransmitter receptor-mediated activation of G-proteins in the brains of suicide victims with mood disorders: selective supersensitivity of α2A-adrenoceptors. Mol Psychiatry 2002; 7: 755–767.

    Article  CAS  PubMed  Google Scholar 

  20. Dean B, Sundram S, Bradbury R, Scarr E, Copolov D . Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 2001; 103: 9–15.

    Article  CAS  PubMed  Google Scholar 

  21. Basavarajappa BS, Hungund BL . Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidyl ethanolamine in SK-N-SH cells. J Neurochem 1999; 72: 522–528.

    Article  CAS  PubMed  Google Scholar 

  22. Basavarajappa BS, Hungund BL . Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTPγS binding in synaptic plasma membrane from chronic ethanol exposed mouse. Brain Res 1999; 64: 429–436.

    Google Scholar 

  23. Hungund BL, Basavarajappa BS, Vadasz C, Kunos G, Rodriguez de Fonseca F et al. Ethanol, endocannabinoids, and the cannabinoidergic signaling system. Alcohol Clin Exp Res 2002; 26: 565–574.

    Article  CAS  PubMed  Google Scholar 

  24. Arango V, Underwood MD, Gubbi AV, Mann JJ . Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 1995; 688: 121–133.

    Article  CAS  PubMed  Google Scholar 

  25. Kelly TM, Mann JJ . Validity of DSM-III-R diagnosis by psychological autopsy: a comparison with antemortem diagnosis. Acta Psychiatr Scand 1996; 94: 337–343.

    Article  CAS  PubMed  Google Scholar 

  26. Lowry OH, Rosebrough NJ, Farr AG, Randall RJ . Protein measurement with folin phenol reagent. J Biol Chem 1951; 193: 265–275.

    CAS  PubMed  Google Scholar 

  27. Gonzalez-Maeso J, Rodriguez-Puertas R, Gabilondo J, Meana JJ . Characterization of receptor mediated [35S]GTPγS binding to cortical membrane from post-mortem human brain. Eur J Pharmacol 2000; 390: 25–36.

    Article  CAS  PubMed  Google Scholar 

  28. Sawada K, Young CE, Barr AM, Longworth K, Takahashi S, Arango V et al. Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness. Mol Psychiatry 2002; 7: 484–492.

    Article  CAS  PubMed  Google Scholar 

  29. Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss C . Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 2002; 34: 346–356.

    Article  Google Scholar 

  30. Gilman AG . G proteins: transducers of receptor-generated signals. Ann Rev Biochem 1987; 56: 615–649.

    Article  CAS  PubMed  Google Scholar 

  31. Kearn CS, Greenberg MJ, DiCamelli R, Kurzawa K, Hillard CJ . Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange. J Neurochem 1999; 72: 2379–2387.

    Article  CAS  PubMed  Google Scholar 

  32. Sim LJ, Selley DE, Childers SR . In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5′-[gamma-[35S]thio]-triphosphate binding. Proc Natl Acad Sci USA 1995; 92: 7242–7246.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS, Young LT . G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J Neurochem 1999; 73: 1121–1126.

    Article  CAS  PubMed  Google Scholar 

  34. Romero J, Berrendero F, Garcia-Gil L, de la Cruz P, Ramos JA, Fernandez-Ruiz JJ . Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5′O-(thio)-triphosphate binding in the basal ganglia of aged rats. Neuroscience 1998; 84: 1075–1083.

    Article  CAS  PubMed  Google Scholar 

  35. Mann JJ . The neurobiology of suicide. Nat Med. 1998; 1; 25–30.

    Article  CAS  PubMed  Google Scholar 

  36. Hollister LE . Health aspect of cannabis: revisited. Int J Neuropsychopharmacol 1998; 1: 71–80.

    Article  CAS  PubMed  Google Scholar 

  37. Mathers DC, Ghodse AH . Cannabis and psychotic illness. Br J Psychiatry 1992; 161: 648–653.

    Article  CAS  PubMed  Google Scholar 

  38. Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D . Elevated endogenous cannabinoids in schizophrenia. Neuroreport 1999; 10: 1665–1667.

    Article  CAS  PubMed  Google Scholar 

  39. Pani L, Gessa GL . The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia. Mol Psychiatry 2002; 7: 247–253.

    Article  CAS  PubMed  Google Scholar 

  40. Kupfer DJ, Detre T, Koral J, Fajans PA . Comment on the ‘amotivational syndrome’ in marijuana smokers. Am J Psychiatry 1973; 130: 1319–1321.

    Article  CAS  PubMed  Google Scholar 

  41. Kreitzer AC, Regehr WG . Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 2001; 29: 717–727.

    Article  CAS  PubMed  Google Scholar 

  42. Takahashi KA, Linden DJ . Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells. J Neurophysiol 2000; 83: 1167–1180.

    Article  CAS  PubMed  Google Scholar 

  43. Kreitzer AC, Regehr WG . Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J Neurosci 2001; 21: RC174.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Wilson RI, Nicoll RA . Endocannabinoid signaling in the brain. Science. 2002; 296: 678–682.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by Grants AA13003 and NARSAD independent investigator award (BLH); AA09004 and MH40210 (VA); MH62185 (JJM). The preliminary findings of this study were presented at Neuroscience meeting. We thank Dr Veeranna, Centre for Dementia Research, NKI, for his technical advice.

Author information

Author notes

  1. B L Hungund and K Y Vinod: BLH and KYV contributed equally to this work.

Authors and Affiliations

  1. New York State Psychiatric Institute, New York, NY, USA

    B L Hungund, S A Kassir, B S Basavarajappa, T B Cooper, J J Mann & V Arango

  2. Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA

    B L Hungund, K Y Vinod, B S Basavarajappa, R Yalamanchili & T B Cooper

  3. Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA

    B L Hungund, T B Cooper, J J Mann & V Arango

  4. Department of Anatomy and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, NY, USA

    V Arango

Authors
  1. B L Hungund
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Y Vinod
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S A Kassir
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B S Basavarajappa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R Yalamanchili
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T B Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J J Mann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. V Arango
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B L Hungund.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hungund, B., Vinod, K., Kassir, S. et al. Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victims. Mol Psychiatry 9, 184–190 (2004). https://doi.org/10.1038/sj.mp.4001376

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001376

Keywords

  • CB1 receptor
  • [35S]GTPγS binding
  • depression
  • suicide
  • prefrontal cortex

This article is cited by

Search

Advanced search

Quick links